| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A0A072TY77 | Nodule Cysteine-Rich (NCR) secreted peptide; | MTR_7g033740; | NULL | 59 | barrel-medic |
| A0A072TMH7 | Transmembrane protein, putative; | MTR_8g027430; | NULL | 372 | barrel-medic |
| A0A072U6V3 | Uncharacterized protein; | MTR_6g018800; | NULL | 130 | barrel-medic |
| A0A072U9F3 | Uncharacterized protein; | MTR_7g050405; | NULL | 151 | barrel-medic |
| A0A072U7M7 | Uncharacterized protein; | MTR_6g033565; | NULL | 68 | barrel-medic |
| A0A072TUB1 | Sensor kinase; | MTR_8g089810; | NULL | 439 | barrel-medic |
| A0A072U6F4 | LuxR family transcriptional regulator, putative; | MTR_6g017240; | NULL | 305 | barrel-medic |
| A0A072U721 | Pathogen-inducible alpha-dioxygenase; | MTR_6g007767; | NULL | 569 | barrel-medic |
| A0A072TN84 | ATP-dependent helicase BRM; | MTR_8g030550; | NULL | 2026 | barrel-medic |
| A0A072TGS1 | LysM type receptor kinase, putative; | NULL | NULL | 145 | barrel-medic |
| A0A072U8B6 | Breast cancer type 2 susceptibility-like protein; | MTR_6g033115; | NULL | 614 | barrel-medic |
| A0A072TCJ7 | Flavin containing amine oxidase; Fragment; | NULL | NULL | 355 | barrel-medic |
| A0A072UEK3 | Uncharacterized protein; | MTR_5g065145; | NULL | 89 | barrel-medic |
| A0A072UE21 | Nodule Cysteine-Rich (NCR) secreted peptide; | MTR_5g059420; | NULL | 59 | barrel-medic |
| A0A072UFZ8 | Uncharacterized protein; | MTR_4g009877; | NULL | 73 | barrel-medic |
| A0A072UB11 | Otubain; | MTR_6g081290; | NULL | 98 | barrel-medic |
| A0A072UAB7 | Polyadenylate-binding protein, putative; | MTR_6g040200; | NULL | 88 | barrel-medic |
| A0A072UIB6 | Lateral organ boundaries (LOB) domain protein; | MTR_6g027700; | NULL | 209 | barrel-medic |
| A0A072UEN3 | Leguminosin group485 secreted peptide; | MTR_5g077715; | NULL | 200 | barrel-medic |
| A0A072U524 | F-box protein, putative; | MTR_6g007130; | NULL | 122 | barrel-medic |
